Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein

Journal of General Virology

Volumn 87, Issue 8, 2006, Pages 2181-2190

  Kang, Heejung ^a   Kim, Eui Tae ^a   Lee, Hye Ra ^a   Park, Jung Jin ^a   Go, Yoon Young ^b   Choi, Cheol Yong ^b   Ahn, Jin Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AXAM; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN IE1; PROTEIN SENP1; PROTEIN SUPR 1; PROTEINASE; SUMO PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BACTERIAL CELL; CELL ASSAY; CELL DISRUPTION; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; INSECT CELL; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS STRAIN;

CELL LINE; CELL NUCLEUS; CELL NUCLEUS STRUCTURES; CYTOMEGALOVIRUS; ENDOPEPTIDASES; HUMANS; IMMEDIATE-EARLY PROTEINS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5; INSECTA;

EID: 33746824547     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81787-0     Document Type: Article

References (46)

1. Adamson, A. L. & Kenney, S. (2001). Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75, 2388-2399.
2. Ahn, J.-H. & Hayward, G. S. (1997). The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. J Virol 71, 4599-4613.
3. Ahn, J.-H. & Hayward, G. S. (2000). Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274, 39-55.
4. Ahn, J.-H., Brignole, E. J., III & Hayward, G. S. (1998). Disruption of PML subnuclear domains by the acidic IEI protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML. Mol Cell Biol 18, 4899-4913.
5. Ahn, J. H., Xu, Y., Jang, W.-J., Matunis, M. J. & Hayward, G. S. (2001). Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9. J Virol 75, 3859-3872.
6. Bailey, D. & O'Hare, P. (2002). Herpes simplex virus 1 ICPO colocalizes with a SUMO-specific protease. J Gen Virol 83, 2951-2964.
7. Bailey, D. & O'Hare, P. (2004). Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J Biol Chem 279, 692-703.
8. Bell, P., Lieberman, P. M. & Maul, G. G. (2000). Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol 74, 11800-11810.
9. Bernardi, R. & Pandolfi, P. P. (2003). Role of PML and the PML-nuclear body in the control of programmed cell death. Oncogene 22, 9048-9057.
10. Boutell, C., Orr, A. & Everett, R. D. (2003). PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICPO. J Virol 77, 8686-8694.
11. Dellaire, G. & Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963-977.
12. Everett R. D. & Maul, G. G. (1994). HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J 13, 5062-5069.
13. Gawn, J. M. & Greaves, R. F. (2002). Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 76, 4441-4455.
14. Gravel, A., Gosselin, J. & Flamand, L. (2002). Human herpesvirus 6 immediate-early 1 protein is a sumoylated nuclear phosphoprotein colocalizing with promyelocytic leukemia protein-associated nuclear bodies. J Biol Chem 277, 19679-19687.
15. Greaves, R. F. & Mocarski, E. S. (1998). Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol 72, 366-379.
16. Green, S., Isseman, P. & Sheer, E. (1988). A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16, 369.
17. Ishov, A. M., Sotnikov, A. G., Negorev, D., Vladimirova, O. V., Neff, N., Kamitani, T., Yeh, E. T. H., Strauss, J. F., III & Maul, G. G. (1999). PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J Cell Biol 147, 221-234.
18. Johnson, E. S. (2004). Protein modification by SUMO. Annu Rev Biochem 73, 355-382.
19. Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T. & Yeh, E. T. H. (1998). Identification of three major sentrinization sites in PML. J Biol Chem 273, 26675-26682.
20. Kentsis, A., Gordon, R. E. & Borden, K. L. (2002). Control of biochemical reactions through supramolecular RING domain self-assembly. Proc Natl Acad Sci U S A 99, 15404-15409.
21. Korioth, F., Maul, G. G., Plachter, B., Stamminger, T. & Frey, J. (1996). The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res 229, 155-158.
22. 3-induced PML or PML/ retinoic acid receptor α degradation. J Exp Med 193, 1361-1371.
23. Lee, H.-R., Kim, D.-J., Lee, J.-M., Choi, C. Y., Ahn, B.-Y., Hayward, G. S. & Ahn, J.-H. (2004). Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells. J Virol 78, 6527-6542.
24. Maul, G. G. & Everett, R. D. (1994). The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICPO. J Gen Virol 75, 1223-1233.
25. Maul, G. G., Guldner, H. H. & Spivack, J. G. (1993). Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICPO). J Gen Virol 74, 2679-2690.
26. Mocarski, E. S. & Tan Courcelle, C. (2001). Cytomegalovirus and their replication. In Fields Virology, 4th edn, pp. 2629-2673. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
27. 491aa is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A 93, 11321-11326.
28. Müller, S. & Dejean, A. (1999). Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol 73, 5137-5143.
29. 2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently. J Cell Sci 116, 513-524.
30. Nevels, M., Brune, W. & Shenk, T. (2004). SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication. J Virol 78, 7803-7812.
31. Pass, R. F. (2001). Cytomegalovirus. In Fields Virology, 4th edn, pp. 2675-2705. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
32. Regad, T., Saib, A., Lallemand-Breitenbach, V., Pandolfi, P. P., de Thé H. & Chelbi-Alix, M. K. (2001). PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 20, 3495-3505.
33. Roth, M. B., Zahler, A. M. & Stolk, J. A. (1991). A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J Cell Biol 115, 587-596.
34. Sadanari, H., Yamada, R., Ohnishi, K., Matsubara, K. & Tanaka, J. (2005). SUMO-1 modification of the major immediate-early (IE) 1 and 2 proteins of human cytomegalovirus is regulated by different mechanisms and modulates the intracellular localization of the IE1, but not IE2, protein. Arch Virol 150, 1763-1782.
35. Salomoni, P. & Pandolfi, P. P. (2002). The role of PML in tumor suppression. Cell 108, 165-170.
36. Seeler, J.-S. & Dejean, A. (2003). Nuclear and unclear functions of SUMO. Nat Rev Mol Cell Biol 4, 690-699.
37. Spengler, M. L., Kurapatwinski, K, Black A. R. & Azizkhan-Clifford, J. (2002). SUMO-1 modification of human cytomegalovirus IE1/IE72. J Virol 76, 2990-2996.
38. Stanton, R., Fox, J. D., Caswell, R., Sherratt, E. & Wilkinson, G. W. G. (2002). Analysis of the human herpesvirus-6 immediate-early 1 protein. J Gen Virol 83, 2811-2820.
39. Tang, O. & Maul, G. G. (2003). Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol 77, 1357-1367.
40. Tatham, M. H., Jaffray, E., Vaughan, O. A., Desterro, J. M. P., Botting, C. H., Naismith, J. H. & Hay, R. T. (2001). Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem 276, 35368-35374.
41. Uchimura, Y., Nakamura, M., Sugasawa, K, Nakao, M. & Saitoh, H. (2004a). Overproduction of eukaryotic SUMO-1- and SUMO-2- conjugated proteins in Escherichia coli. Anal Biochem 331, 204-206.
42. Uchimura, Y., Nakao, M. & Saitoh, H. (2004b). Generation of SUMO-1 modified proteins in E. coli: towards understanding the biochemistry/ structural biology of the SUMO-1 pathway. FEBS Lett 564, 85-90.
43. Wilkinson, G. W., Kelly, C., Sinclair, J. H. & Rickards, C. (1998). Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product. J Gen Virol 79, 1233-1245.
44. Xu, Y., Ahn, J.-H., Chang, M., apRhys, C. M., Chiou, C.-J., Zong, J., Matunis, M. J. & Hayward, G. S. (2001). Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression. J Virol 75, 10683-10695.
45. Zhong, S., Muller, S., Ronchetti, S., Freemont, P. S., Dejean, A. & Pandolfi, P. P. (2000a). Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.
46. Zhong, S., Salomoni, P. & Pandolfi, P. P. (2000b). The transcriptional role of PML and the nuclear body. Nat Cell Biol 2, E85-E90.